Wichterman Troy 4

What Happened
Troy Wichterman, Chief Financial Officer of BioLife Solutions (BLFS), was granted two restricted stock awards on 2026-02-24 totaling 96,016 shares (31,150 and 64,866). On the same date, 25,525 shares were disposed of (withheld) to satisfy tax withholding obligations at an indicated per-share value of $22.65, totaling $578,141. The grants were reported as awards (code A) and the withholding as tax withholding (code F).

Key Details

• Transaction date: 2026-02-24; Form 4 filed 2026-02-26 (appears timely).
• Grants: 31,150 and 64,866 restricted shares (grant price N/A for restricted stock awards).
• Withholding: 25,525 shares withheld at $22.65 per share for taxes; total value reported $578,141.
• Footnotes:
  • F1: One award is part of the 2023 Omnibus Performance Incentive Plan and vests 25% on the first anniversary, then quarterly over 12 quarters (part of 2026 compensation).
  • F2: The market-based award vested at ~156% of the originally granted amount based on total shareholder return vs. peer group for 2024–2025.
  • F3: The 25,525 shares represent shares withheld to cover tax withholding obligations upon vesting.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Type of activity: awards/grants (acquisitions) with shares withheld for taxes — not an open-market sale.

Context

• The awards are compensation-related restricted stock that vested (in part based on performance metrics). The withheld shares were surrendered to cover tax liabilities on those vesting events; this is a routine administrative action and not necessarily a signal of bearish insider selling.
• Market-based vesting that paid out at ~156% indicates performance metrics exceeded targets for the relevant period, resulting in a larger-than-granted payout.